Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1988 Jun;43(6):446–450. doi: 10.1136/thx.43.6.446

Comparison of the efficacy of preservative free ipratropium bromide and Atrovent nebuliser solution.

P Rafferty 1, R Beasley 1, S T Holgate 1
PMCID: PMC461308  PMID: 2971274

Abstract

The paradoxical bronchoconstriction observed with commercially available isotonic ipratropium bromide nebuliser solution (Atrovent) in patients with asthma results from an adverse reaction to the preservatives, benzalkonium chloride and ethylenediaminetetra-acetic acid (EDTA). The airway response to inhaled Atrovent and preservative free ipratropium bromide nebuliser solutions has been examined in a double blind study. On separate occasions 30 asthmatic subjects inhaled 2 ml of the solutions and airway calibre was measured in terms of FEV1 for 45 minutes. Atrovent nebuliser solution provoked a greater than 20% fall in FEV1 in five of the 30 subjects, whereas this did not occur after preservative free ipratropium bromide. Inhalation of the preservative free solution resulted in more rapid and greater overall bronchodilatation than Atrovent, with mean maximum increases in FEV1 of 29.2% and 18.5% respectively. It is concluded that the risk of paradoxical bronchoconstriction with ipratropium bromide is considerably reduced by removal of benzalkonium chloride and EDTA and that preservative free ipratropium bromide is a more potent bronchodilator than the currently available Atrovent solution.

Full text

PDF
448

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beasley C. R., Rafferty P., Holgate S. T. Bronchoconstrictor properties of preservatives in ipratropium bromide (Atrovent) nebuliser solution. Br Med J (Clin Res Ed) 1987 May 9;294(6581):1197–1198. doi: 10.1136/bmj.294.6581.1197-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chai H., Farr R. S., Froehlich L. A., Mathison D. A., McLean J. A., Rosenthal R. R., Sheffer A. L., Spector S. L., Townley R. G. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol. 1975 Oct;56(4):323–327. doi: 10.1016/0091-6749(75)90107-4. [DOI] [PubMed] [Google Scholar]
  3. Clark R. J. Exacerbation of asthma after nebulised beclomethasone diproprionate. Lancet. 1986 Sep 6;2(8506):574–575. doi: 10.1016/s0140-6736(86)90140-6. [DOI] [PubMed] [Google Scholar]
  4. Connolly C. K. Adverse reaction to ipratropium bromide. Br Med J (Clin Res Ed) 1982 Oct 2;285(6346):934–935. doi: 10.1136/bmj.285.6346.934. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Downes H., Hirshman C. A. Calcium chelators increase airway responsiveness. J Appl Physiol (1985) 1985 Jul;59(1):92–95. doi: 10.1152/jappl.1985.59.1.92. [DOI] [PubMed] [Google Scholar]
  6. Howarth P. H. Bronchoconstriction in response to ipratropium bromide. Br Med J (Clin Res Ed) 1983 Jun 4;286(6380):1825–1826. doi: 10.1136/bmj.286.6380.1825-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Innocenti A. Asma professionale da benzalconio cloruro. Med Lav. 1978 Nov-Dec;69(6):713–715. [PubMed] [Google Scholar]
  8. Jolobe O. M. Adverse reaction to ipratropium bromide. Br Med J (Clin Res Ed) 1982 Nov 13;285(6352):1425–1426. doi: 10.1136/bmj.285.6352.1425-d. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Mann J. S., Howarth P. H., Holgate S. T. Bronchoconstriction induced by ipratropium bromide in asthma: relation to hypotonicity. Br Med J (Clin Res Ed) 1984 Aug 25;289(6443):469–469. doi: 10.1136/bmj.289.6443.469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Patel K. R., Tullett W. M. Bronchoconstriction in response to ipratropium bromide. Br Med J (Clin Res Ed) 1983 Apr 23;286(6374):1318–1318. doi: 10.1136/bmj.286.6374.1318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Rafferty P., Beasley R., Holgate S. T. The contribution of histamine to immediate bronchoconstriction provoked by inhaled allergen and adenosine 5' monophosphate in atopic asthma. Am Rev Respir Dis. 1987 Aug;136(2):369–373. doi: 10.1164/ajrccm/136.2.369. [DOI] [PubMed] [Google Scholar]
  12. Rafferty P., Beasley R., Howarth P. H., Mann J. S., Holgate S. T. Bronchoconstriction induced by nebulised ipratropium bromide: relation to the bromide ion. Br Med J (Clin Res Ed) 1986 Dec 13;293(6561):1538–1539. doi: 10.1136/bmj.293.6561.1538. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Tomioka M., Ida S., Shindoh Y., Ishihara T., Takishima T. Mast cells in bronchoalveolar lumen of patients with bronchial asthma. Am Rev Respir Dis. 1984 Jun;129(6):1000–1005. doi: 10.1164/arrd.1984.129.6.1000. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES